| Ytd | -12.99% | |
| 1y | 19.73% |
| Open | 676.43 | Prev Close | 675.19 | Low | 672.00 | High | 676.80 | Mkt Cap | 69.56B |
| Vol | 38.02K | Avg Vol | 1.00M | EPS | 45.63 | P/E | 14.80 | Forward P/E | 14.81 |
| Beta | 0.24 | Short Ratio | 3.20 | Inst. Own | 92.18% | Dividend | 3.76 | Div Yield | 0.56 |
| Ex Div Date | 05-20 | Earning | 07-30 | 50-d Avg | 644.17 | 200-d Avg | 705.27 | 1yr Est | 822.45 |
REGN News
SAN FRANCISCO, July 22, 2026 /PRNewswire/ -- Regeneron Pharmaceuticals (NASDAQ: REGN) faces a securi
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP a
SAN FRANCISCO, July 21, 2026 /PRNewswire/ -- Regeneron Pharmaceuticals (NASDAQ: REGN) faces a securi
NEW YORK--(BUSINESS WIRE)---- $REGN #BFA--Regeneron Sued for Securities Fraud after Revealing Failed
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has
LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights l
NEW YORK, July 21, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholde
Ryan Crowe Regeneron securities defendant liability allegations focus on investor-facing statements
Baader Bank Aktiengesellschaft boosted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN
Assetmark Inc. boosted its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) by 9
AlTi Global Inc. boosted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) by 312.7% du
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP alerts investors in Regeneron Phar
LOS ANGELES, July 20, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litiga
LOS ANGELES, July 20, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action law
New York, New York--(Newsfile Corp. - July 19, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationa
[url="]The DJS Law Group[/url] reminds investors of a class action lawsuit against Regeneron Pharmac
LOS ANGELES--(BUSINESS WIRE)--Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - C
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, reminds investors o
LOS ANGELES--(BUSINESS WIRE)---- $REGN--REGN Investors Have Opportunity to Lead Regeneron Pharmaceut
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities cl
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suf
SAN DIEGO, July 17, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was fi
All three can be bought on the dip.
NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi and Kors
SAN DIEGO--(BUSINESS WIRE)---- $REGN #Health--Robbins LLP informs stockholders that a class action w
Piper Sandler analyst Biren Amin maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overwei
Morgan Stanley analyst Matthew Harrison maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a
RBC Capital analyst Brian Abrahams maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Secto
Truist Securities analyst Gregory Renza maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a
Top Wall Street analysts upgraded FSLR, META, WM, NET, and REGN stocks. Check out analyst ratings pa
Benchmark analyst Robert Wasserman upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) from Hold to
HSBC analyst Rajesh Kumar maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and lowers
Cantor Fitzgerald analyst Carter Gould maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a O
FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after recei
The FDA will review the New Drug Application (NDA) under Priority Review with a target action date i
Ocular outlines FDA-aligned AXPAXLI NDA plan for wet AMD by Q4 2026, revises SOL-R study design, and
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
- Expanded collaboration builds upon research momentum in developing next-generation bispecific immu
Nasdaq sinks 1.1% as AMAT, MU, ORCL and Vertiv crater on AI capex jitters, while WTI tops $106 and t
Top analysts changed outlook on top names. Keybanc, Leerink, Wedbush, DA Davidson, Benchmark, Piper
Wall Street analysts changed ratings on top stocks. Check out the complete list on Benzinga's an
Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the st
U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Mon
Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $